publication venue for
- Strategies to decrease inequalities in cancer therapeutics, care and prevention. 2023
- Dinaciclib synergizes with BH3 mimetics targeting BCL-2 and BCL-XL in multiple myeloma cell lines partially dependent on MCL-1 and in plasma cells from patients.. 17. 2023
- Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer.. 17. 2023
- Novel TCF4:TCF12 heterodimer inhibits glioblastoma growth. 2023
- NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells.. 16. 2022
- The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. 2022
- Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients. 2022
- FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer. 2021
- hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote its translation in stressed melanoma cells. 2021
- The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings. 2021
- KRAS mutant rectal cancer cells interact with surrounding fibroblasts to deplete the extracellular matrix. 2021
- Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up-regulation.. 15. 2021
- RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K-RAS mutant tumors.. 14. 2020
- Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells.. 14. 2020
- PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.. 14. 2020
- NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.. 14. 2020
- Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.. 11. 2017
- Improving fascin inhibitors to block tumor cell migration and metastasis.. 10. 2016
- Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.. 10. 2015
- EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer.. 10. 2015
- Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: Repertoire of somatic genetic alterations and clonal relationships.. 10. 2015
- Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.. 10. 2015
- Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion.. 9. 2014
- Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective study.. 9. 2014
- The immune-related role of BRAF in melanoma.. 9. 2014
- Computational analysis of image-based drug profiling predicts synergistic drug combinations: applications in triple-negative breast cancer.. 8. 2014
- Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.. 8. 2014
- Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.. 8. 2013
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.. 8. 2013
- The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer.. 7. 2013
- Characterizing DNA methylation patterns in pancreatic cancer genome.. 3. 2009
- Overexpression of SnoN/SkiL, amplified at the 3q26.2 locus, in ovarian cancers: a role in ovarian pathogenesis.. 2. 2008
- Molecular imaging for personalized cancer care. 2012